Drug pair given with surgery helps bladder cancer patients live longer
A drug pair helped bladder cancer patients who cannot take a common chemo drug. In the VOLGA trial, patients got durvalumab and enfortumab vedotin along with surgery. After two years, 78.4% of them were alive. That compared with 69.4% of patients who had surgery alone. Thomas Powles of Barts Cancer Center in London presented it in Madrid.
Where this came from. One outlet reported this. We read it, then wrote the sixty words above.